| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/27/2009 | CN101439185A Method for preparing composite preparation for treating lung cancer |
| 05/27/2009 | CN101439184A Method for preparing saccharose lipid covalent conjugate nano material |
| 05/27/2009 | CN101439183A Method for preparing medicament adjuvant from starch |
| 05/27/2009 | CN101439182A Somatostatin receptor mediated tumor-targeted medicament composition |
| 05/27/2009 | CN101439181A Stable water injection medicament composition containing Ulinastatin |
| 05/27/2009 | CN101439180A Medicament composition for improving stability of Ulinastatin |
| 05/27/2009 | CN101439107A Chinese medicine granule containing haw thorn extract and preparation method thereof |
| 05/27/2009 | CN101439099A Chinese medicine granule containing red paeonia extract and preparation method thereof |
| 05/27/2009 | CN101439087A Chinese medicine granule containing salvia root extract and preparation method thereof |
| 05/27/2009 | CN101439086A Chinese medicine granule containing total phenolic acids in salvia root and preparation method thereof |
| 05/27/2009 | CN101439085A Chinese medicine granule containing agastache extract and preparation method thereof |
| 05/27/2009 | CN101439084A Chinese medicine granule containing agastache extract and preparation method thereof |
| 05/27/2009 | CN101439083A Chinese medicine soft capsules for clearing wind heat and clearing nasal passage, as well as preparation method and quality control method |
| 05/27/2009 | CN101439082A Chinese medicine granule containing sophora root extract and preparation method thereof |
| 05/27/2009 | CN101439079A Chinese medicine granule containing total saponins in astragalus and preparation method thereof |
| 05/27/2009 | CN101439078A Chinese medicine granule containing astragalus extract and preparation method thereof |
| 05/27/2009 | CN101439068A Chinese medicine granule containing silymarin and preparation method thereof |
| 05/27/2009 | CN101439063A Chinese medicine granular formulation containing Chinese angelica extract and preparation method thereof |
| 05/27/2009 | CN101439062A Chinese medicine granule containing andrographolide and preparation method thereof |
| 05/27/2009 | CN101439058A Compound Chinese medicine gingko granule and preparation method thereof |
| 05/27/2009 | CN101439056A Technique for preparing Tremella fuciformis spores polysaccharide soft capsules |
| 05/27/2009 | CN101439053A Chinese medicine rapid-release preparation for oral cavity and method for producing the same |
| 05/27/2009 | CN101439048A Chinese medicine glue rapid-release preparation for oral cavity and method for producing the same |
| 05/27/2009 | CN101439043A Teniposide injection and preparation method thereof |
| 05/27/2009 | CN101439037A Alprostadil lipid complexes and micelle composition thereof for injection |
| 05/27/2009 | CN101439034A Tanshinone IIA lipid complexes and micelle composition thereof for injection |
| 05/27/2009 | CN101439033A Polyenic taxusol lipid complexes and micelle composition thereof for injection |
| 05/27/2009 | CN101439032A Paclitaxel lipid complexes and micelle composition thereof for injection |
| 05/27/2009 | CN101439030A Pharmaceutical composition containing lycopene and preparation method thereof |
| 05/27/2009 | CN101439028A Hypromellose composition and application thereof in preparing plant base medicinal capsule |
| 05/27/2009 | CN101439026A Controlled release preparation containing doxazosin or salt thereof and preparation method thereof |
| 05/27/2009 | CN101439024A Abuse-resistant opioid dosage form |
| 05/27/2009 | CN101439021A Compound diclofenac sodium, methopterin flexible lipidosome and preparation method thereof |
| 05/27/2009 | CN101439020A Polyenic taxusol nano lipid carrier and preparation method thereof |
| 05/27/2009 | CN101439019A Paclitaxel nano lipid carrier and preparation method thereof |
| 05/27/2009 | CN101439017A Method for preparing polymer aqueous solution formulation of taxane anti-tumor medicament |
| 05/27/2009 | CN101439016A Bendamustine and potentiating agent thereof carried by anti-cancer medicine sustained-release injection |
| 05/27/2009 | CN101439015A Pharmaceutical composition with enhanced bioavailability |
| 05/27/2009 | CN100491532C Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 05/27/2009 | CN100491449C Controllable biologically degradable polyester superfine fibrous film material |
| 05/27/2009 | CN100491397C Method and compositions for generating human monoclonal antibodies |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100490915C Otolaryngological delivery device |
| 05/27/2009 | CN100490901C Tetramethylpyrazine derivatives modified silk fibroin protein fiber anti-coagulant material and its preparation method |
| 05/27/2009 | CN100490900C Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition |
| 05/27/2009 | CN100490899C Pharmaceutical compositions |
| 05/27/2009 | CN100490898C Non-toxic ionic liquid, preparation method and its application |
| 05/27/2009 | CN100490897C Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 05/27/2009 | CN100490887C Suppository and preparation thereof |
| 05/27/2009 | CN100490823C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 05/27/2009 | CN100490814C Voglibose dispersion tablet |
| 05/27/2009 | CN100490812C Compisition as substitution of phthalocyanine cooperator and low density lipoprotein and its preparation process |
| 05/27/2009 | CN100490810C Flashmelt oral dosage formulation |
| 05/27/2009 | CN100490809C Tablet comprising cetirizine and pseudoephedrine |
| 05/27/2009 | CN100490807C Cephalofruxin ester liposome, its preparation and medicinal composition containing it |
| 05/27/2009 | CN100490805C Composition for the transdermal delivery of fentanyl |
| 05/27/2009 | CN100490804C Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 05/27/2009 | CN100490798C Quick disintegrated tablet or oral cavity disintegrated tablet containing L-glutamic acid and azulene sodium sulfonate and making method thereof |
| 05/27/2009 | CN100490797C Pharmaceutical compositions |
| 05/27/2009 | CN100490795C Red sage root salvianolic acid A injection formulation for treating cardiovascular diseases and preparation process thereof |
| 05/27/2009 | CN100490790C Enteric coated omeprazole pellets capsule and the preparing method thereof |
| 05/27/2009 | CN100490784C Method for preparing protein or polypeptide medicine slow-releasing microball |
| 05/27/2009 | CN100490782C Methanesulfonic acid pazufloxacin gel droplet for ear and its preparation |
| 05/26/2009 | US7538216 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 05/26/2009 | US7538207 Polyepitope carrier protein |
| 05/26/2009 | US7538193 Using deoxy-S-nitrosohemoglobin and glutathione, cysteine and/or N-acetylcysteine to treat and prevent ischemic injury, hypertension, angina, reperfusion injury and inflammation |
| 05/26/2009 | US7538192 Nucleotide sequence/polypeptide fusion for use as capture tool on solid supports during genomic analysis |
| 05/26/2009 | US7538182 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 05/26/2009 | US7538137 Nutraceutical; aqueous extract of Sibiraea leaves; obesity, lipid metabolism, hypoglycemic agent, hair growth, healthy food |
| 05/26/2009 | US7538093 Compositions and methods for therapeutic use |
| 05/26/2009 | US7538092 Oligosaccharides linked by amide, imine,ether, ester, carbonate, carbamate, urea, thioester bond to active agent produce hydrophilicity; easily produced with homogeneity, predictable, desirable pharmacokinetic profile, enhanced biocompatibility |
| 05/26/2009 | US7538091 D-retro-inverso amino acid sequence transporter peptide conjugated to nucleic acid biological effector; translocation across the membrane of pancreatic B-cells |
| 05/26/2009 | US7538081 Incorporating cyclohexyloxy alcohol compound in fragrance composition |
| 05/26/2009 | US7537931 a cancer which expresses epidermal growth factor receptor; blocking ligand activation of a receptor; binding of monoclonal antibody 2C4 to ErbB2; chemotherapeutic agents are 5-fluorouracil leucovorin, levamisole |
| 05/26/2009 | US7537773 Chemodenervating pharmaceutical as anti-inflammatory agent |
| 05/26/2009 | US7537755 Interferon-alpha polypeptides and conjugates |
| 05/26/2009 | US7537752 Mixture of chelate compound and active material in vehicle |
| 05/26/2009 | CA2562938C Peg-functional nucleic acid conjugate |
| 05/26/2009 | CA2541498C Controlled release delivery system for nasal applications |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2494165C Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/26/2009 | CA2465386C Use of glycosaminoglycans and zinc derivatives for insect bites, stings and the like |
| 05/26/2009 | CA2440578C Oral peptide pharmaceutical dosage form and method of production |
| 05/26/2009 | CA2436668C Novel succinate salt of o-desmethyl-venlafaxine |
| 05/26/2009 | CA2411754C 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents |
| 05/26/2009 | CA2399870C Topically applied clotting material |
| 05/26/2009 | CA2393072C Mono- and disaccharide derivatives |
| 05/26/2009 | CA2366702C Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| 05/26/2009 | CA2360418C Spheronised self-emulsifying system for hydrophobic and water-sensitive agents |
| 05/26/2009 | CA2355077C Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 05/26/2009 | CA2339495C Phospholipids with unsaturated alkyl and acyl chains |
| 05/26/2009 | CA2295512C Prostaglandin product |
| 05/26/2009 | CA2230492C Human growth hormone variants |
| 05/26/2009 | CA2227532C Stabilized aqueous steroid immunoassay standards with cyclodextrins |
| 05/26/2009 | CA2215254C Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same |
| 05/26/2009 | CA2174325C Non-antigenic branched polymer conjugates |
| 05/26/2009 | CA2146783C Preparation of further diagnostic agents |
| 05/22/2009 | WO2009065022A2 Low density lipoprotein receptor-mediated sirna delivery |
| 05/22/2009 | WO2009064983A1 Methods and compositions for treating dry eye |
| 05/22/2009 | WO2009064460A2 Gastrointestinal delivery systems |